{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:25:26Z","timestamp":1794576326779,"version":"4.9.1"},"reference-count":174,"publisher":"Bentham Science Publishers Ltd.","issue":"6","funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R15EY029813"],"award-info":[{"award-number":["R15EY029813"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2020,5,11]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>The thiol (-SH) functional group is found in a number of drug compounds and confers a unique combination of useful properties. Thiol-containing drugs can reduce radicals and other toxic electrophiles, restore cellular thiol pools, and form stable complexes with heavy metals such as lead, arsenic, and copper. Thus, thiols can treat a variety of conditions by serving as radical scavengers, GSH prodrugs, or metal chelators. Many of the compounds discussed here have been in use for decades, yet continued exploration of their properties has yielded new understanding in recent years, which can be used to optimize their clinical application and provide insights into the development of new treatments. The purpose of this narrative review is to highlight the biochemistry of currently used thiol drugs within the context of developments reported in the last five years. More specifically, this review focuses on thiol drugs that represent the standard of care for their associated conditions, including N-acetylcysteine, 2,3-meso-dimercaptosuccinic acid, British anti-Lewisite, D-penicillamine, amifostine, and others. Reports of novel dosing regimens, delivery strategies, and clinical applications for these compounds were examined with an eye toward emerging approaches to address a wide range of medical conditions in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1389557519666191119144100","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T05:43:22Z","timestamp":1574228602000},"page":"513-529","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Medicinal Thiols: Current Status and New Perspectives"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0013-8213","authenticated-orcid":true,"given":"Annalise R.","family":"Pfaff","sequence":"first","affiliation":[{"name":"Department of Chemistry, Missouri University of Science and Technology, Rolla, Missouri, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4060-4223","authenticated-orcid":true,"given":"Justin","family":"Beltz","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Missouri University of Science and Technology, Rolla, Missouri, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-3172","authenticated-orcid":true,"given":"Emily","family":"King","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Missouri University of Science and Technology, Rolla, Missouri, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-4274","authenticated-orcid":true,"given":"Nuran","family":"Ercal","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Missouri University of Science and Technology, Rolla, Missouri, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-30018-9","author":"Laher I.","year":"2014","unstructured":"Laher I.; Systems Biology of Free Radicals and Antioxidants 2014","journal-title":"Systems Biology of Free Radicals and Antioxidants"},{"key":"ref=2","author":"Gutteridge J.M.C.","year":"2015","unstructured":"Gutteridge J.M.C.; Halliwell B.; Free Radicals in Biology and Medicine 2015","journal-title":"Free Radicals in Biology and Medicine"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1089\/ars.2016.6665","volume":"25","author":"Ratliff B.B.","year":"2016","unstructured":"Ratliff B.B.; Abdulmahdi W.; Pawar R.; Wolin M.S.; Oxidant Mechanisms in Renal Injury and Disease. Antioxid Redox Signal 2016,25(3),119-146","journal-title":"Antioxid Redox Signal"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6097417","volume":"2016","author":"Qui\u00f1onez-Flores C.M.","year":"2016","unstructured":"Qui\u00f1onez-Flores C.M.; Gonz\u00e1lez-Ch\u00e1vez S.A.; Del R\u00edo N\u00e1jera D.; Pacheco-Tena C.; Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review. BioMed Res Int 2016,2016","journal-title":"BioMed Res Int"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"R453","DOI":"10.1016\/j.cub.2014.03.034","volume":"24","author":"Schieber M.","year":"2014","unstructured":"Schieber M.; Chandel N.S.; ROS function in redox signaling and oxidative stress. Curr Biol 2014,24(10),R453-R462","journal-title":"Curr Biol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12967-017-1338-x","volume":"15","author":"Smith T.A.","year":"2017","unstructured":"Smith T.A.; Kirkpatrick D.R.; Smith S.; Smith T.K.; Pearson T.; Kailasam A.; Herrmann K.Z.; Schubert J.; Agrawal D.K.; Radioprotective agents to prevent cellular damage due to ionizing radiation. J Transl Med 2017,15(1),232","journal-title":"J Transl Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1039\/9781782623892","volume":"Vol. 8","author":"Crichton E.","year":"2016","unstructured":"Crichton E.; Ward R.J.; Hider R.C.; Metal Chelation in Medicine 2016,Vol. 8,322","journal-title":"Metal Chelation in Medicine"},{"key":"ref=8","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-9438-0","author":"Huxtable R.J.","year":"1986","unstructured":"Huxtable R.J.; Biochemistry of Sulfur 1986","journal-title":"Biochemistry of Sulfur"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/534314a","volume":"534","author":"Nosengo N.","year":"2016","unstructured":"Nosengo N.; Can you teach old drugs new tricks? Nature 2016,534(7607),314-316","journal-title":"Nature"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1586\/17512433.2014.904744","volume":"7","author":"Blieden M.","year":"2014","unstructured":"Blieden M.; Paramore L.C.; Shah D.; Ben-Joseph R.; A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert Rev Clin Pharmacol 2014,7(3),341-348","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/hep.20293","volume":"40","author":"Lee W.M.","year":"2004","unstructured":"Lee W.M.; Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004,40(1),6-9","journal-title":"Hepatology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/hep.20948","volume":"42","author":"Larson A.M.","year":"2005","unstructured":"Larson A.M.; Polson J.; Fontana R.J.; Davern T.J.; Lalani E.; Hynan L.S.; Reisch J.S.; Schi\u00f8dt F.V.; Ostapowicz G.; Shakil A.O.; Lee W.M.; Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology Acute Liver Failure Study Group2005,42(6),1364-1372","journal-title":"Hepatology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/lt.500050102","volume":"5","author":"Schi\u00f8dt F.V.","year":"1999","unstructured":"Schi\u00f8dt F.V.; Atillasoy E.; Shakil A.O.; Schiff E.R.; Caldwell C.; Kowdley K.V.; Stribling R.; Crippin J.S.; Flamm S.; Somberg K.A.; Rosen H.; McCashland T.M.; Hay J.E.; Lee W.M.; Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999,5(1),29-34","journal-title":"Liver Transpl Surg"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/pds.1191","volume":"15","author":"Nourjah P.","year":"2006","unstructured":"Nourjah P.; Ahmad S.R.; Karwoski C.; Willy M.; Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States. Pharmacoepidemiol Drug Saf 2006,15(6),398-405","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJMct0708278","volume":"359","author":"Heard K.J.","year":"2008","unstructured":"Heard K.J.; Acetylcysteine for acetaminophen poisoning. N Engl J Med 2008,359(3),285-292","journal-title":"N Engl J Med"},{"key":"ref=16","first-page":"131","volume":"4","author":"Yoon E.","year":"2016","unstructured":"Yoon E.; Babar A.; Choudhary M.; Kutner M.; Pyrsopoulos N.; Acetaminophen-Induced Hepatotoxicity: a Comprehensive Update. J Clin Transl Hepatol 2016,4(2),131-142","journal-title":"J Clin Transl Hepatol"},{"key":"ref=17","author":"Macherey A-C.","year":"2011","unstructured":"Macherey A-C.; Dansette P.M.; The Practice of Medicinal Chemistry 2011","journal-title":"The Practice of Medicinal Chemistry"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cbi.2015.11.002","volume":"242","author":"Klop\u010di\u010d I.","year":"2015","unstructured":"Klop\u010di\u010d I.; Pober\u017enik M.; Mavri J.; Dolenc M.S.; A quantum chemical study of the reactivity of acetaminophen (paracetamol) toxic metabolite N-acetyl-p-benzoquinone imine with deoxyguanosine and glutathione. Chem Biol Interact 2015,242,407-414","journal-title":"Chem Biol Interact"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","volume":"31","author":"James L.P.","year":"2003","unstructured":"James L.P.; Mayeux P.R.; Hinson J.A.; Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003,31(12),1499-1506","journal-title":"Drug Metab Dispos"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/hep.23267","volume":"51","author":"Saito C.","year":"2010","unstructured":"Saito C.; Zwingmann C.; Jaeschke H.; Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology 2010,51(1),246-254","journal-title":"Hepatology"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phrs.2016.02.020","volume":"109","author":"Ghanem C.I.","year":"2016","unstructured":"Ghanem C.I.; P\u00e9rez M.J.; Manautou J.E.; Mottino A.D.; Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity. Pharmacol Res 2016,109,119-131","journal-title":"Pharmacol Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"11326","DOI":"10.1021\/ac402390q","volume":"85","author":"Kim J.W.","year":"2013","unstructured":"Kim J.W.; Ryu S.H.; Kim S.; Lee H.W.; Lim M.S.; Seong S.J.; Kim S.; Yoon Y.R.; Kim K.B.; Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans. Anal Chem 2013,85(23),11326-11334","journal-title":"Anal Chem"},{"key":"ref=23","author":"Chiew A.L.","year":"2018","unstructured":"Chiew A.L.; Gluud C.; Brok J.; Buckley N.A.; Interventions for paracetamol (acetaminophen) overdose. Cochrane Database Syst Rev 2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.coph.2007.04.005","volume":"7","author":"Atkuri K.R.","year":"2007","unstructured":"Atkuri K.R.; Mantovani J.J.; Herzenberg L.A.; Herzenberg L.A.; N-Acetylcysteine--a safe antidote for cysteine\/glutathione deficiency. Curr Opin Pharmacol 2007,7(4),355-359","journal-title":"Curr Opin Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1074\/mcp.RA118.000875","volume":"17","author":"Chan J.C.Y.","year":"2018","unstructured":"Chan J.C.Y.; Soh A.C.K.; Kioh D.Y.Q.; Li J.; Verma C.; Koh S.K.; Beuerman R.W.; Zhou L.; Chan E.C.Y.; Reactive Metabolite-induced Protein Glutathionylation: A Potentially Novel Mechanism Underlying Acetaminophen Hepatotoxicity. Mol Cell Proteomics 2018,17(10),2034-2050","journal-title":"Mol Cell Proteomics"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/01.mop.0000152622.05168.9e","volume":"17","author":"Marzullo L.","year":"2005","unstructured":"Marzullo L.; An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr 2005,17(2),239-245","journal-title":"Curr Opin Pediatr"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","volume":"319","author":"Smilkstein M.J.","year":"1988","unstructured":"Smilkstein M.J.; Knapp G.L.; Kulig K.W.; Rumack B.H.; Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988,319(24),1557-1562","journal-title":"N Engl J Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-2125.2011.04067.x","volume":"73","author":"Craig D.G.","year":"2012","unstructured":"Craig D.G.; Bates C.M.; Davidson J.S.; Martin K.G.; Hayes P.C.; Simpson K.J.; Staggered overdose pattern and delay to hospital presentation are associated with adverse outcomes following paracetamol-induced hepatotoxicity. Br J Clin Pharmacol 2012,73(2),285-294","journal-title":"Br J Clin Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/fcp.12184","volume":"30","author":"Kane A.E.","year":"2016","unstructured":"Kane A.E.; Huizer-Pajkos A.; Mach J.; McKenzie C.; Mitchell S.J.; de Cabo R.; Jones B.; Cogger V.; Le Couteur D.G.; Hilmer S.N.; N-Acetyl cysteine does not prevent liver toxicity from chronic low-dose plus subacute high-dose paracetamol exposure in young or old mice. Fundam Clin Pharmacol 2016,30(3),263-275","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"218","DOI":"10.5811\/westjem.2012.4.6885","volume":"14","author":"Green J.L.","year":"2013","unstructured":"Green J.L.; Heard K.J.; Reynolds K.M.; Albert D.; Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis. West J Emerg Med 2013,14(3),218-226","journal-title":"West J Emerg Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.clinthera.2011.08.005","volume":"33","author":"Blackford M.G.","year":"2011","unstructured":"Blackford M.G.; Felter T.; Gothard M.D.; Reed M.D.; Assessment of the clinical use of intravenous and oral N-acetylcysteine in the treatment of acute acetaminophen poisoning in children: a retrospective review. Clin Ther 2011,33(9),1322-1330","journal-title":"Clin Ther"},{"key":"ref=32","first-page":"178","volume":"20","author":"Pauley K.A.","year":"2015","unstructured":"Pauley K.A.; Sandritter T.L.; Lowry J.A.; Algren D.A.; Evaluation of an Alternative Intravenous N-Acetylcysteine Regimen in Pediatric Patients. J Pediatr Pharmacol Ther 2015,20(3),178-185","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1345\/aph.1K685","volume":"42","author":"Hayes B.D.","year":"2008","unstructured":"Hayes B.D.; Klein-Schwartz W.; Doyon S.; Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother 2008,42(6),766-770","journal-title":"Ann Pharmacother"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1586\/17474124.2016.1127756","volume":"10","author":"Stine J.G.","year":"2016","unstructured":"Stine J.G.; Lewis J.H.; Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review. Expert Rev Gastroenterol Hepatol 2016,10(4),517-536","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/15563650.2013.799677","volume":"51","author":"Schmidt L.E.","year":"2013","unstructured":"Schmidt L.E.; Identification of patients at risk of anaphylactoid reactions to N-acetylcysteine in the treatment of paracetamol overdose. Clin Toxicol (Phila) 2013,51(6),467-472","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/fcp.12437","volume":"33","author":"Pickering G.","year":"2019","unstructured":"Pickering G.; Macian N.; Papet I.; Dual\u00e9 C.; Coudert C.; Pereira B.; N-acetylcysteine prevents glutathione decrease and does not interfere with paracetamol antinociceptive effect at therapeutic dosage: a randomized double-blind controlled trial in healthy subjects. Fundam Clin Pharmacol 2019,33(3),303-311","journal-title":"Fundam Clin Pharmacol"},{"key":"ref=37","first-page":"114","volume":"3","author":"Kelly G.S.","year":"1998","unstructured":"Kelly G.S.; Clinical applications of N-acetylcysteine. Altern Med Rev 1998,3(2),114-127","journal-title":"Altern Med Rev"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5694\/mja15.00614","volume":"203","author":"Chiew A.L.","year":"2015","unstructured":"Chiew A.L.; Fountain J.S.; Graudins A.; Isbister G.K.; Reith D.; Buckley N.A.; Summary statement: new guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust 2015,203(5),215-218","journal-title":"Med J Aust"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00228-017-2277-4","volume":"73","author":"Wong A.","year":"2017","unstructured":"Wong A.; Landersdorfer C.; Graudins A.; Pharmacokinetic modelling of modified acetylcysteine infusion regimens used in the treatment of paracetamol poisoning. Eur J Clin Pharmacol 2017,73(9),1103-1110","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/15563650.2017.1359620","volume":"56","author":"Wong A.","year":"2018","unstructured":"Wong A.; Gunja N.; McNulty R.; Graudins A.; Analysis of an 8-hour acetylcysteine infusion protocol for repeated supratherapeutic ingestion (RSTI) of paracetamol. Clin Toxicol (Phila) 2018,56(3),199-203","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.redox.2016.10.001","volume":"10","author":"Du K.","year":"2016","unstructured":"Du K.; Ramachandran A.; Jaeschke H.; Oxidative stress during acetaminophen hepatotoxicity: Sources, pathophysiological role and therapeutic potential. Redox Biol 2016,10,148-156","journal-title":"Redox Biol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.fct.2016.10.021","volume":"98","author":"Duan L.","year":"2016","unstructured":"Duan L.; Davis J. S.; Woolbright B. L.; Du K.; Cahkraborty M.; Weemhoff J.; Jaeschke H.; Bourdi M.; Differential susceptibility to acetaminophen-induced liver injury in sub-strains of C57BL\/6 mice: 6N versus 6J Food Chem Toxicol 2016,98(Pt B),107-118","journal-title":"Food Chem Toxicol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1136\/bmj.2.6099.1395","volume":"2","author":"Hughes R.D.","year":"1977","unstructured":"Hughes R.D.; Gazzard B.G.; Hanid M.A.; Trewby P.N.; Murray-Lyon I.M.; Davis M.; Williams R.; Bennet J.R.; Controlled trial of cysteamine and dimercaprol after paracetamol overdose. BMJ 1977,2(6099),1395","journal-title":"BMJ"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/030006058100900314","volume":"9","author":"Hamlyn A.N.","year":"1981","unstructured":"Hamlyn A.N.; Lesna M.; Record C.O.; Smith P.A.; Watson A.J.; Meredith T.; Volans G.N.; Crome P.; Methionine and cysteamine in paracetamol (acetaminophen) overdose, prospective controlled trial of early therapy. J Int Med Res 1981,9(3),226-231","journal-title":"J Int Med Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"18582","DOI":"10.1021\/acsomega.8b02943","volume":"3","author":"Casta\u00f1eda-Arriaga R.","year":"2018","unstructured":"Casta\u00f1eda-Arriaga R.; P\u00e9rez-Gonz\u00e1lez A.; Galano A.; Chemical Protectors against the toxic effects of paracetamol (Acetaminophen) and its meta analogue: Preventing protein arylation. ACS Omega 2018,3(12),18582-18591","journal-title":"ACS Omega"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1292\/jvms.16-0325","volume":"78","author":"Koyama R.","year":"2017","unstructured":"Koyama R.; Mizuta R.; Acrolein scavengers, cysteamine and N-benzylhydroxylamine, reduces the mouse liver damage after acetaminophen overdose. J Vet Med Sci 2017,78(12),1903-1905","journal-title":"J Vet Med Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"i2579","DOI":"10.1136\/bmj.i2579","volume":"353","author":"Buckley N.A.","year":"2016","unstructured":"Buckley N.A.; Dawson A.H.; Isbister G.K.; Treatments for paracetamol poisoning. BMJ 2016,353,i2579","journal-title":"BMJ"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.toxlet.2015.11.008","volume":"241","author":"Khayyat A.","year":"2016","unstructured":"Khayyat A.; Tobwala S.; Hart M.; Ercal N.; N-acetylcysteine amide, a promising antidote for acetaminophen toxicity. Toxicol Lett 2016,241,133-142","journal-title":"Toxicol Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1016\/j.bmcl.2017.09.054","volume":"27","author":"Theodosis-Nobelos P.","year":"2017","unstructured":"Theodosis-Nobelos P.; Athanasekou C.; Rekka E.A.; Dual antioxidant structures with potent anti-inflammatory, hypolipidemic and cytoprotective properties. Bioorg Med Chem Lett 2017,27(21),4800-4804","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/acs.chemrestox.6b00291","volume":"30","author":"More S.S.","year":"2017","unstructured":"More S.S.; Nugent J.; Vartak A.P.; Nye S.M.; Vince R.; Hepatoprotective effect of \u03c8-Glutathione in a murine model of Acetaminophen-Induced liver toxicity. Chem Res Toxicol 2017,30(3),777-784","journal-title":"Chem Res Toxicol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/bcpt.13058","volume":"123","author":"Nilsson J.L.A.","year":"2018","unstructured":"Nilsson J.L.A.; Blomgren A.; Nilsson U.J.; H\u00f6gest\u00e4tt E.D.; Grundemar L.; N\u2032-Bis(2-mercaptoethyl)isophthalamide binds electrophilic paracetamol metabolites and prevents paracetamol-induced liver toxicity. Basic Clin Pharmacol Toxicol 2018,123(5),589-593","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1080\/10715760801998638","volume":"42","author":"Ates B.","year":"2008","unstructured":"Ates B.; Abraham L.; Ercal N.; Antioxidant and free radical scavenging properties of N-acetylcysteine amide (NACA) and comparison with N-acetylcysteine (NAC). Free Radic Res 2008,42(4),372-377","journal-title":"Free Radic Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1177\/1535370214549520","volume":"240","author":"Tobwala S.","year":"2015","unstructured":"Tobwala S.; Khayyat A.; Fan W.; Ercal N.; Comparative evaluation of N-acetylcysteine and N-acetylcysteineamide in acetaminophen-induced hepatotoxicity in human hepatoma HepaRG cells. Exp Biol Med (Maywood) 2015,240(2),261-272","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.2174\/092986710793213760","volume":"17","author":"Baran E.J.","year":"2010","unstructured":"Baran E.J.; Chelation therapies: a chemical and biochemical perspective. Curr Med Chem 2010,17(31),3658-3672","journal-title":"Curr Med Chem"},{"key":"ref=55","volume":"Vol. 565","year":"1994","unstructured":"A Century of Progress Coordination Chemistry1994,Vol. 565","journal-title":"A Century of Progress"},{"key":"ref=56","year":"2012","unstructured":"Low level lead exposure harms children: a renewed call for primary prevention (A report of the Advisory Committee on Childhood Lead Poisoning Prevention) Advisory Committee for Childhood Lead Poisoning Prevention2012","journal-title":"Low level lead exposure harms children: a renewed call for primary prevention (A report of the Advisory Committee on Childhood Lead Poisoning Prevention)"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tox.2011.03.001","volume":"283","author":"Jomova K.","year":"2011","unstructured":"Jomova K.; Valko M.; Advances in metal-induced oxidative stress and human disease. Toxicology 2011,283(2-3),65-87","journal-title":"Toxicology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2105\/AJPH.2015.303003","volume":"106","author":"Hanna-Attisha M.","year":"2016","unstructured":"Hanna-Attisha M.; LaChance J.; Sadler R.C.; Champney Schnepp A.; Elevated blood lead levels in children associated with the flint drinking water crisis: A spatial analysis of risk and public health response. Am J Public Health 2016,106(2),283-290","journal-title":"Am J Public Health"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/1471-2164-13-344","volume":"13","author":"Gillis B.S.","year":"2012","unstructured":"Gillis B.S.; Arbieva Z.; Gavin I.M.; Analysis of lead toxicity in human cells. BMC Genomics 2012,13,344","journal-title":"BMC Genomics"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1515\/9783110434330-008","volume":"17","author":"Farkas E.","year":"2017","unstructured":"Farkas E.; Bugly\u00f3 P.; Lead(II) Complexes of Amino Acids, Peptides, and other related ligands of biological interest. Met Ions Life Sci 2017,17,17","journal-title":"Met Ions Life Sci"},{"key":"ref=61","first-page":"353","volume":"21","author":"Kern M.","year":"2000","unstructured":"Kern M.; Wisniewski M.; Cabell L.; Audesirk G.; Inorganic lead and calcium interact positively in activation of calmodulin. Neurotoxicology 2000,21(3),353-363","journal-title":"Neurotoxicology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2478\/v10102-012-0009-2","volume":"5","author":"Flora G.","year":"2012","unstructured":"Flora G.; Gupta D.; Tiwari A.; Toxicity of lead: A review with recent updates. Interdiscip Toxicol 2012,5(2),47-58","journal-title":"Interdiscip Toxicol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2174\/1568026013394831","volume":"1","author":"Ercal N.","year":"2001","unstructured":"Ercal N.; Gurer-Orhan H.; Aykin-Burns N.; Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001,1(6),529-539","journal-title":"Curr Top Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0891-5849(00)00413-5","volume":"29","author":"Gurer H.","year":"2000","unstructured":"Gurer H.; Ercal N.; Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000,29(10),927-945","journal-title":"Free Radic Biol Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s12011-012-9490-x","volume":"150","author":"Kasperczyk A.","year":"2012","unstructured":"Kasperczyk A.; Prokopowicz A.; Dobrakowski M.; Pawlas N.; Kasperczyk S.; The effect of occupational lead exposure on blood levels of zinc, iron, copper, selenium and related proteins. Biol Trace Elem Res 2012,150(1-3),49-55","journal-title":"Biol Trace Elem Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/0003-9861(89)90271-3","volume":"271","author":"Monteiro H.P.","year":"1989","unstructured":"Monteiro H.P.; Abdalla D.S.; Augusto O.; Bechara E.J.; Free radical generation during delta-aminolevulinic acid autoxidation: induction by hemoglobin and connections with porphyrinpathies. Arch Biochem Biophys 1989,271(1),206-216","journal-title":"Arch Biochem Biophys"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0304-4165(86)90102-9","volume":"881","author":"Monteiro H.P.","year":"1986","unstructured":"Monteiro H.P.; Abdalla D.S.; Faljoni-Al\u00e0rio A.; Bechara E.J.; Generation of active oxygen species during coupled autoxidation of oxyhemoglobin and delta-aminolevulinic acid. Biochim Biophys Acta 1986,881(1),100-106","journal-title":"Biochim Biophys Acta"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0300-483X(98)00074-2","volume":"128","author":"G\u00fcrer H.","year":"1998","unstructured":"G\u00fcrer H.; Ozg\u00fcnes H.; Neal R.; Spitz D.R.; Er\u00e7al N.; Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats. Toxicology 1998,128(3),181-189","journal-title":"Toxicology"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/(SICI)1099-0461(1998)12:6<345:AID-JBT4>3.0.CO;2-V","volume":"12","author":"Othman A.I.","year":"1998","unstructured":"Othman A.I.; El Missiry M.A.; Role of selenium against lead toxicity in male rats. J Biochem Mol Toxicol 1998,12(6),345-349","journal-title":"J Biochem Mol Toxicol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/toxics2020258","volume":"2","author":"Tobwala S.","year":"2014","unstructured":"Tobwala S.; Wang H-J.; Carey J.; Banks W.; Ercal N.; Effects of lead and cadmium on brain endothelial cell survival, monolayer permeability, and crucial oxidative stress markers in an in vitro model of the blood-brain barrier. Toxics 2014,2(2),258-275","journal-title":"Toxics"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jtemb.2014.10.001","volume":"31","author":"Aaseth J.","year":"2015","unstructured":"Aaseth J.; Skaug M.A.; Cao Y.; Andersen O.; Chelation in metal intoxication--Principles and paradigms. J Trace Elem Med Biol 2015,31,260-266","journal-title":"J Trace Elem Med Biol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1007\/s00204-017-2100-0","volume":"91","author":"Bj\u00f8rklund G.","year":"2017","unstructured":"Bj\u00f8rklund G.; Mutter J.; Aaseth J.; Metal chelators and neurotoxicity: lead, mercury, and arsenic. Arch Toxicol 2017,91(12),3787-3797","journal-title":"Arch Toxicol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.3390\/ijerph7072745","volume":"7","author":"Flora S.J.","year":"2010","unstructured":"Flora S.J.; Pachauri V.; Chelation in metal intoxication. Int J Environ Res Public Health 2010,7(7),2745-2788","journal-title":"Int J Environ Res Public Health"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123790","volume":"19","author":"Zhai H.","year":"2018","unstructured":"Zhai H.; Wang Y.; Wang M.; Liu S.; Yu F.; Gao C.; Li G.; Wu Q.; Construction of a glutathione-responsive and silica-based nanocomposite for controlled release of chelator dimercaptosuccinic acid. Int J Mol Sci 2018,19(12)","journal-title":"Int J Mol Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/clpt.2010.132","volume":"88","author":"Kosnett M.J.","year":"2010","unstructured":"Kosnett M.J.; Chelation for heavy metals (arsenic, lead, and mercury): protective or perilous? Clin Pharmacol Ther 2010,88(3),412-415","journal-title":"Clin Pharmacol Ther"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jtemb.2016.03.013","volume":"38","author":"Andersen O.","year":"2016","unstructured":"Andersen O.; Aaseth J.; A review of pitfalls and progress in chelation treatment of metal poisonings. J Trace Elem Med Biol 2016,38,74-80","journal-title":"J Trace Elem Med Biol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/15563650.2018.1478424","volume":"56","author":"Sakthithasan K.","year":"2018","unstructured":"Sakthithasan K.; L\u00e9vy P.; Poupon J.; Garnier R.; A comparative study of edetate calcium disodium and dimercaptosuccinic acid in the treatment of lead poisoning in adults. Clin Toxicol (Phila) 2018,56(11),1143-1149","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.molstruc.2018.09.027","volume":"1176","author":"Kaviani S.","year":"2019","unstructured":"Kaviani S.; Shahab S.; Sheikhi M.; Ahmadianarog M.; DFT study on the selective complexation of meso-2,3-dimercaptosuccinic acid with toxic metal ions (Cd, Hg and Pb) for pharmaceutical and biological applications. J Mol Struct 2019,1176,901-907","journal-title":"J Mol Struct"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/15563650.2016.1263855","volume":"55","author":"van Eijkeren J.C.","year":"2017","unstructured":"van Eijkeren J.C.; Olie J.D.; Bradberry S.M.; Vale J.A.; de Vries I.; Clewell H.J.; Meulenbelt J.; Hunault C.C.; Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead. Clin Toxicol (Phila) 2017,55(2),133-141","journal-title":"Clin Toxicol (Phila)"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1517\/17425247.2016.1160890","volume":"13","author":"Yadav A.","year":"2016","unstructured":"Yadav A.; Flora S.J.; Nano drug delivery systems: a new paradigm for treating metal toxicity. Expert Opin Drug Deliv 2016,13(6),831-841","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1177\/0960327115591373","volume":"35","author":"Alcaraz-Contreras Y.","year":"2016","unstructured":"Alcaraz-Contreras Y.; Mendoza-Lozano R.P.; Mart\u00ednez-Alcaraz E.R.; Mart\u00ednez-Alfaro M.; Gallegos-Corona M.A.; Ram\u00edrez-Morales M.A.; V\u00e1zquez-Guevara M.A.; Silymarin and dimercaptosuccinic acid ameliorate lead-induced nephrotoxicity and genotoxicity in rats. Hum Exp Toxicol 2016,35(4),398-403","journal-title":"Hum Exp Toxicol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1021\/acs.chemrestox.5b00323","volume":"28","author":"Sisombath N.S.","year":"2015","unstructured":"Sisombath N.S.; Jalilehvand F.; Similarities between N-Acetylcysteine and Glutathione in Binding to Lead(II) Ions. Chem Res Toxicol 2015,28(12),2313-2324","journal-title":"Chem Res Toxicol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00244-004-0025-0","volume":"49","author":"Aykin-Burns N.","year":"2005","unstructured":"Aykin-Burns N.; Franklin E.A.; Ercal N.; Effects of N-acetylcysteine on lead-exposed PC-12 cells. Arch Environ Contam Toxicol 2005,49(1),119-123","journal-title":"Arch Environ Contam Toxicol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2010.11.013","volume":"201","author":"Penugonda S.","year":"2011","unstructured":"Penugonda S.; Ercal N.; Comparative evaluation of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) on glutamate and lead-induced toxicity in CD-1 mice. Toxicol Lett 2011,201(1),1-7","journal-title":"Toxicol Lett"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12011-017-1009-z","volume":"180","author":"Pedroso T.F.","year":"2017","unstructured":"Pedroso T.F.; Oliveira C.S.; Fonseca M.M.; Oliveira V.A.; Pereira M.E.; Effects of Zinc and N-Acetylcysteine in damage caused by lead exposure in young rats. Biol Trace Elem Res 2017,180(2),275-284","journal-title":"Biol Trace Elem Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1177\/0748233715571152","volume":"32","author":"Kasperczyk S.","year":"2016","unstructured":"Kasperczyk S.; Dobrakowski M.; Kasperczyk A.; Romuk E.; Rykaczewska-Czerwi\u0144ska M.; Pawlas N.; Birkner E.; Effect of N-acetylcysteine administration on homocysteine level, oxidative damage to proteins, and levels of iron (Fe) and Fe-related proteins in lead-exposed workers. Toxicol Ind Health 2016,32(9),1607-1618","journal-title":"Toxicol Ind Health"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0891-5849(99)00036-2","volume":"27","author":"Gurer H.","year":"1999","unstructured":"Gurer H.; Ozgunes H.; Oztezcan S.; Ercal N.; Antioxidant role of alpha-lipoic acid in lead toxicity. Free Radic Biol Med 1999,27(1-2),75-81","journal-title":"Free Radic Biol Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/096032719901800104","volume":"18","author":"Gurer H.","year":"1999","unstructured":"Gurer H.; Neal R.; Yang P.; Oztezcan S.; Ercal N.; Captopril as an antioxidant in lead-exposed Fischer 344 rats. Hum Exp Toxicol 1999,18(1),27-32","journal-title":"Hum Exp Toxicol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.sjbs.2016.05.005","volume":"23","author":"Aldahmash B.A.","year":"2016","unstructured":"Aldahmash B.A.; El-Nagar D.M.; Antioxidant effects of captopril against lead acetate-induced hepatic and splenic tissue toxicity in Swiss albino mice. Saudi J Biol Sci 2016,23(6),667-673","journal-title":"Saudi J Biol Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0891-5849(98)00214-7","volume":"26","author":"Neal R.","year":"1999","unstructured":"Neal R.; Cooper K.; Kellogg G.; Gurer H.; Ercal N.; Effects of some sulfur-containing antioxidants on lead-exposed lenses. Free Radic Biol Med 1999,26(1-2),239-243","journal-title":"Free Radic Biol Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0300-483X(98)00104-8","volume":"130","author":"Neal R.","year":"1998","unstructured":"Neal R.; Cooper K.; Gurer H.; Ercal N.; Effects of N-acetylcysteine and 2,3-dimercaptosuccinic acid on lead induced oxidative stress in rat lenses. Toxicology 1998,130(2-3),167-174","journal-title":"Toxicology"},{"key":"ref=92","first-page":"OL543","volume":"50","author":"Flora S.J.","year":"2004","unstructured":"Flora S.J.; Pande M.; Kannan G.M.; Mehta A.; Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cell Mol Biol (Noisy-le-grand), 2004,50,OL543-OL551","journal-title":"Cell Mol Biol (Noisy-le-grand),"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0891-5849(96)00020-2","volume":"21","author":"Ercal N.","year":"1996","unstructured":"Ercal N.; Treeratphan P.; Hammond T.C.; Matthews R.H.; Grannemann N.H.; Spitz D.R.; In vivo indices of oxidative stress in lead-exposed C57BL\/6 mice are reduced by treatment with meso-2,3-dimercaptosuccinic acid or N-acetylcysteine. Free Radic Biol Med 1996,21(2),157-161","journal-title":"Free Radic Biol Med"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/MGC-170231","volume":"16","author":"Ioannou P.V.","year":"2017","unstructured":"Ioannou P.V.; Vachliotis D.G.; Chrissanthopoulos A.; Chelation therapy: The interaction of British Anti-Lewisite (BAL) with some heavy metal cations of p and d blocks. Main Group Chem 2017,16(2),125-139","journal-title":"Main Group Chem"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jinorgbio.2015.10.004","volume":"153","author":"Harper L.K.","year":"2015","unstructured":"Harper L.K.; Bayse C.A.; Modeling the chelation of As(III) in lewisite by dithiols using density functional theory and solvent-assisted proton exchange. J Inorg Biochem 2015,153,60-67","journal-title":"J Inorg Biochem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.1021\/acs.inorgchem.8b00894","volume":"57","author":"Szekeres L.I.","year":"2018","unstructured":"Szekeres L.I.; Gyurcsik B.; Kiss T.; Kele Z.; Jancs\u00f3 A.; Interaction of arsenous acid with the dithiol-type chelator British Anti-Lewisite (BAL): Structure and stability of species formed in an unexpectedly complex system. Inorg Chem 2018,57(12),7191-7200","journal-title":"Inorg Chem"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnmol.2017.00010","volume":"10","author":"Katerji M.","year":"2017","unstructured":"Katerji M.; Barada K.; Jomaa M.; Kobeissy F.; Makkawi A.K.; Abou-Kheir W.; Usta J.; Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible implications on wilson disease patients. Front Mol Neurosci 2017,10,10","journal-title":"Front Mol Neurosci"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/inorganics6040126","volume":"6","author":"Gaur K.","year":"2018","unstructured":"Gaur K.; V\u00e1zquez-Salgado A.; Duran-Camacho G.; Dominguez-Martinez I.; Benjam\u00edn-Rivera J.; Fern\u00e1ndez-Vega L.; Carmona Sarabia L.; Cruz Garc\u00eda A.; P\u00e9rez-Deliz F.; M\u00e9ndez Rom\u00e1n J.; Vega-Cartagena M.; Loza-Rosas S.; Rodriguez Acevedo X.; Tinoco A.; Iron and Copper intracellular chelation as an anticancer drug strategy. Inorganics 2018,6(4),126","journal-title":"Inorganics"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1002\/hep.29490","volume":"67","author":"Pfeiffenberger J.","year":"2018","unstructured":"Pfeiffenberger J.; Beinhardt S.; Gotthardt D.N.; Haag N.; Freissmuth C.; Reuner U.; Gauss A.; Stremmel W.; Schilsky M.L.; Ferenci P.; Weiss K.H.; Pregnancy in Wilson\u2019s disease: Management and outcome. Hepatology 2018,67(4),1261-1269","journal-title":"Hepatology"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"Roberts E.A.","year":"2008","unstructured":"Roberts E.A.; Schilsky M.L.; Diagnosis and treatment of Wilson disease: an update. Hepatology American Association for Study of Liver Diseases (AASLD)2008,47(6),2089-2111","journal-title":"Hepatology"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.clinre.2018.03.007","volume":"42","author":"Poujois A.","year":"2018","unstructured":"Poujois A.; Woimant F.; Wilson\u2019s disease: A 2017 update. Clin Res Hepatol Gastroenterol 2018,42(6),512-520","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jtemb.2017.05.008","volume":"44","author":"Hachm\u00f6ller O.","year":"2017","unstructured":"Hachm\u00f6ller O.; Zibert A.; Zischka H.; Sperling M.; Groba S.R.; Gr\u00fcnewald I.; Wardelmann E.; Schmidt H.H.; Karst U.; Spatial investigation of the elemental distribution in Wilson\u2019s disease liver after d-penicillamine treatment by LA-ICP-MS. J Trace Elem Med Biol 2017,44,26-31","journal-title":"J Trace Elem Med Biol"},{"key":"ref=103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190509","volume":"13","author":"Rasheed S.","year":"2018","unstructured":"Rasheed S.; S\u00e1nchez S.S.; Yousuf S.; Honor\u00e9 S.M.; Choudhary M.I.; Drug repurposing: In-vitro anti-glycation properties of 18 common drugs. PLoS One 2018,13(1)","journal-title":"PLoS One"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/B978-0-444-63625-6.00015-X","volume":"142","author":"Cz\u0142onkowska A.","year":"2017","unstructured":"Cz\u0142onkowska A.; Litwin T.; Wilson disease - currently used anticopper therapy. Handb Clin Neurol 2017,142,181-191","journal-title":"Handb Clin Neurol"},{"key":"ref=105","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14653","author":"Helmy H.","year":"2019","unstructured":"Helmy H.; Fahmy M.; Abdel Aziz H.; Ghobrial C.; Abdel Hameed N.; El-Karaksy H.; Urinary abnormalities in children and adolescents with Wilson disease before and during treatment with d-penicillamine. J Gastroenterol Hepatol 2019","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1038\/s41598-018-19873-2","volume":"8","author":"Smirnova J.","year":"2018","unstructured":"Smirnova J.; Kabin E.; J\u00e4rving I.; Bragina O.; T\u00f5ugu V.; Plitz T.; Palumaa P.; Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. \u03b1-Lipoic acid as a potential anti-copper agent. Sci Rep 2018,8(1),1463","journal-title":"Sci Rep"},{"key":"ref=107","doi-asserted-by":"publisher","DOI":"10.1002\/0470862106.ia052","author":"Conry R.R.","year":"2006","unstructured":"Conry R.R.; Encyclopedia of Inorganic Chemistry, 1st ed; King, R.B.; Crabtree, R.H.; Lukehart, C.M.; Atwood, D.A.; Scott, R.A., Eds.; 2006","journal-title":"Encyclopedia of Inorganic Chemistry,"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"20413","DOI":"10.1039\/C5DT02129D","volume":"44","author":"K\u00f6nigsberger L.C.","year":"2015","unstructured":"K\u00f6nigsberger L.C.; K\u00f6nigsberger E.; Hefter G.; May P.M.; Formation constants of copper(I) complexes with cysteine, penicillamine and glutathione: implications for copper speciation in the human eye. Dalton Trans 2015,44(47),20413-20425","journal-title":"Dalton Trans"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jinorgbio.2011.11.024","volume":"107","author":"Rubino J.T.","year":"2012","unstructured":"Rubino J.T.; Franz K.J.; Coordination chemistry of copper proteins: how nature handles a toxic cargo for essential function. J Inorg Biochem 2012,107(1),129-143","journal-title":"J Inorg Biochem"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.freeradbiomed.2017.04.001","volume":"108","author":"Sciegienka S.J.","year":"2017","unstructured":"Sciegienka S.J.; Solst S.R.; Falls K.C.; Schoenfeld J.D.; Klinger A.R.; Ross N.L.; Rodman S.N.; Spitz D.R.; Fath M.A.; D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via HO-mediated oxidative stress. Free Radic Biol Med 2017,108,354-361","journal-title":"Free Radic Biol Med"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1215\/S1152851704000869","volume":"7","author":"Brem S.","year":"2005","unstructured":"Brem S.; Grossman S.A.; Carson K.A.; New P.; Phuphanich S.; Alavi J.B.; Mikkelsen T.; Fisher J.D.; Phase 2 trial of copper depletion and penicillamine as antiangiogenesis therapy of glioblastoma. Neuro-oncol New Approaches to Brain Tumor Therapy CNS Consortium2005,7(3),246-253","journal-title":"Neuro-oncol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7150\/ijms.3635","volume":"9","author":"Baskar R.","year":"2012","unstructured":"Baskar R.; Lee K.A.; Yeo R.; Yeoh K.W.; Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012,9(3),193-199","journal-title":"Int J Med Sci"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"26880","DOI":"10.3390\/ijms161125991","volume":"16","author":"Kim B.M.","year":"2015","unstructured":"Kim B.M.; Hong Y.; Lee S.; Liu P.; Lim J.H.; Lee Y.H.; Lee T.H.; Chang K.T.; Hong Y.; Therapeutic implications for overcoming radiation resistance in cancer therapy. Int J Mol Sci 2015,16(11),26880-26913","journal-title":"Int J Mol Sci"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2016.11.039","volume":"107","author":"Abbotts R.","year":"2017","unstructured":"Abbotts R.; Wilson D.M.; Coordination of DNA single strand break repair. Free Radic Biol Med 2017,107,228-244","journal-title":"Free Radic Biol Med"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","volume":"26","author":"Ceccaldi R.","year":"2016","unstructured":"Ceccaldi R.; Rondinelli B.; D\u2019Andrea A.D.; Repair pathway choices and consequences at the double-strand break. Trends Cell Biol 2016,26(1),52-64","journal-title":"Trends Cell Biol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mrfmmm.2004.09.012","volume":"571","author":"Cadet J.","year":"2005","unstructured":"Cadet J.; Sage E.; Douki T.; Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 2005,571(1-2),3-17","journal-title":"Mutat Res"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1055\/s-0035-1553209]","volume":"187","author":"Kuefner M.","year":"2015","unstructured":"Kuefner M.; Brand M.; Engert C.; Schwab S.; Uder M.; Radiation induced dna double-strand breaks in radiology. R\u00f6Fo - Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren, 2015,187(10),872-878","journal-title":"R\u00f6Fo - Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren,"},{"key":"ref=118","first-page":"1254","volume":"78","author":"Gerber D.E.","year":"2008","unstructured":"Gerber D.E.; Chan T.A.; Recent advances in radiation therapy. Am Fam Physician 2008,78(11),1254-1262","journal-title":"Am Fam Physician"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/med.21386","volume":"36","author":"Kamran M.Z.","year":"2016","unstructured":"Kamran M.Z.; Ranjan A.; Kaur N.; Sur S.; Tandon V.; Radioprotective agents: Strategies and translational advances. Med Res Rev 2016,36(3),461-493","journal-title":"Med Res Rev"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3892\/or.10.5.1609","volume":"10","author":"Brenner B.","year":"2003","unstructured":"Brenner B.; Wasserman L.; Beery E.; Nordenberg J.; Schechter J.; Gutman H.; Fenig E.; Variable cytotoxicity of amifostine in malignant and non-malignant cell lines. Oncol Rep 2003,10(5),1609-1613","journal-title":"Oncol Rep"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1021\/acs.jmedchem.5b01628","volume":"59","author":"Hofer M.","year":"2016","unstructured":"Hofer M.; Falk M.; Kom\u016frkov\u00e1 D.; Falkov\u00e1 I.; Ba\u010d\u00edkov\u00e1 A.; Klejdus B.; Pag\u00e1\u010dov\u00e1 E.; \u0160tefan\u010d\u00edkov\u00e1 L.; Weiterov\u00e1 L.; Angelis K.J.; Kozubek S.; Du\u0161ek L.; Galbav\u00fd \u0160.; Two new faces of amifostine: Protector from DNA damage in normal cells and inhibitor of DNA repair in cancer cells. J Med Chem 2016,59(7),3003-3017","journal-title":"J Med Chem"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.2147\/IJN.S140462","volume":"13","author":"Graham K.","year":"2018","unstructured":"Graham K.; Unger E.; Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Int J Nanomedicine 2018,13,6049-6058","journal-title":"Int J Nanomedicine"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3164\/jcbn.15-130","volume":"60","author":"Ueno M.","year":"2017","unstructured":"Ueno M.; Matsumoto S.; Matsumoto A.; Manda S.; Nakanishi I.; Matsumoto K.I.; Mitchell J.B.; Krishna M.C.; Anzai K.; Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging. J Clin Biochem Nutr 2017,60(3),151-155","journal-title":"J Clin Biochem Nutr"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/09553002.2016.1175681","volume":"92","author":"Kavaz E.","year":"2016","unstructured":"Kavaz E.; Peri\u015fano\u011flu U.; Ekinci N.; \u00d6zdem\u0131r Y.; Determination of energy absorption and exposure buildup factors by using G-P fitting approximation for radioprotective agents. Int J Radiat Biol 2016,92(7),380-387","journal-title":"Int J Radiat Biol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00774-014-0599-1","volume":"33","author":"Felice P.A.","year":"2015","unstructured":"Felice P.A.; Gong B.; Ahsan S.; Deshpande S.S.; Nelson N.S.; Donneys A.; Tchanque-Fossuo C.; Morris M.D.; Buchman S.R.; Raman spectroscopy delineates radiation-induced injury and partial rescue by amifostine in bone: a murine mandibular model. J Bone Miner Metab 2015,33(3),279-284","journal-title":"J Bone Miner Metab"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1097\/IAE.0000000000000493","volume":"35","author":"Akkus Yildirim B.","year":"2015","unstructured":"Akkus Yildirim B.; \u00c7etin E.; Topkan E.; Ozyigit G.; Cengiz M.; Surucu S.; Usubutun A.; Akyol F.; Prevention of Radiation-Induced Retinopathy with Amifostine in Wistar Albino Rats. Retina 2015,35(7),1458-1464","journal-title":"Retina"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.ebd.6401295","volume":"19","author":"Ferraiolo D.M.","year":"2018","unstructured":"Ferraiolo D.M.; Veitz-Keenan A.; Insufficient evidence for interventions to prevent dry mouth and salivary gland dysfunction post head and neck radiotherapy. Evid Based Dent 2018,19(1),30-31","journal-title":"Evid Based Dent"},{"key":"ref=128","first-page":"5","volume":"36","author":"Devine A.","year":"2016","unstructured":"Devine A.; Marignol L.; Potential of Amifostine for Chemoradiotherapy and Radiotherapy-associated Toxicity Reduction in Advanced NSCLC: A Meta-Analysis. Anticancer Res 2016,36(1),5-12","journal-title":"Anticancer Res"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3357\/AMHP.4735.2017","volume":"88","author":"McLaughlin M.F.","year":"2017","unstructured":"McLaughlin M.F.; Donoviel D.B.; Jones J.A.; Novel indications for commonly used medications as radiation protectants in spaceflight. Aerosp Med Hum Perform 2017,88(7),665-676","journal-title":"Aerosp Med Hum Perform"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11095-018-2386-5","volume":"35","author":"Ranganathan K.","year":"2018","unstructured":"Ranganathan K.; Simon E.; Lynn J.; Snider A.; Zhang Y.; Nelson N.; Donneys A.; Rodriguez J.; Buchman L.; Reyna D.; Lipka E.; Buchman S.R.; Novel formulation strategy to improve the feasibility of amifostine administration. Pharm Res 2018,35(5),99","journal-title":"Pharm Res"},{"key":"ref=131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012529.pub2","author":"Lawrie T.A.","year":"2018","unstructured":"Lawrie T.A.; Green J.T.; Beresford M.; Wedlake L.; Burden S.; Davidson S.E.; Lal S.; Henson C.C.; Andreyev H.J.N.; Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev 2018","journal-title":"Cochrane Database Syst Rev"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/HP.0000000000000326","volume":"109","author":"Chen C.H.","year":"2015","unstructured":"Chen C.H.; Kuo M.L.; Wang J.L.; Liao W.C.; Chang L.C.; Chan L.P.; Lin J.; CCM-AMI, a Polyethylene Glycol Micelle with Amifostine, as an Acute Radiation Syndrome Protectant in C57BL\/6 Mice. Health Phys 2015,109(3),242-248","journal-title":"Health Phys"},{"key":"ref=133","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201800421","volume":"7","author":"Xie J.","year":"2018","unstructured":"Xie J.; Wang C.; Zhao F.; Gu Z.; Zhao Y.; Application of multifunctional nanomaterials in radioprotection of healthy tissues. Adv Healthc Mater 2018,7(20)","journal-title":"Adv Healthc Mater"},{"key":"ref=134","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22050834","volume":"22","author":"Hofer M.","year":"2017","unstructured":"Hofer M.; Hoferov\u00e1 Z.; Depe\u0161 D.; Falk M.; Combining pharmacological countermeasures to attenuate the Acute Radiation Syndrome-A concise review. Molecules 2017,22(5)","journal-title":"Molecules"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fendo.2013.00157","volume":"4","author":"Rodgers K.E.","year":"2013","unstructured":"Rodgers K.E.; Dizerega G.S.; Contribution of the local RAS to hematopoietic function: A novel therapeutic target. Front Endocrinol (Lausanne) 2013,4,157","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.radonc.2014.11.017","volume":"114","author":"van der Veen S.J.","year":"2015","unstructured":"van der Veen S.J.; Ghobadi G.; de Boer R.A.; Faber H.; Cannon M.V.; Nagle P.W.; Brandenburg S.; Langendijk J.A.; van Luijk P.; Coppes R.P.; ACE inhibition attenuates radiation-induced cardiopulmonary damage. Radiother Oncol 2015,114(1),96-103","journal-title":"Radiother Oncol"},{"key":"ref=137","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/COC.0000000000000289","volume":"41","author":"Small W.","year":"2018","unstructured":"Small W.; James J.L.; Moore T.D.; Fintel D.J.; Lutz S.T.; Movsas B.; Suntharalingam M.; Garces Y.I.; Ivker R.; Moulder J.; Pugh S.; Berk L.B.; Utility of the ACE inhibitor captopril in mitigating radiation-associated pulmonary toxicity in lung cancer: Results from NRG oncology RTOG 0123. Am J Clin Oncol 2018,41(4),396-401","journal-title":"Am J Clin Oncol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1038\/s41598-019-38651-2","volume":"9","author":"McCart E.A.","year":"2019","unstructured":"McCart E.A.; Lee Y.H.; Jha J.; Mungunsukh O.; Rittase W.B.; Summers T.A.; Muir J.; Day R.M.; Delayed captopril administration mitigates hematopoietic injury in a murine model of total body irradiation. Sci Rep 2019,9(1),2198","journal-title":"Sci Rep"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1667\/RR14113.1","volume":"184","author":"Islam A.","year":"2015","unstructured":"Islam A.; Bolduc D.L.; Zhai M.; Kiang J.G.; Swift J.M.; Captopril increases survival after whole-body ionizing irradiation but decreases survival when combined with skin-burn trauma in mice. Radiat Res 2015,184(3),273-279","journal-title":"Radiat Res"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1667\/RR1892.1","volume":"173","author":"Kiang J.G.","year":"2010","unstructured":"Kiang J.G.; Jiao W.; Cary L.H.; Mog S.R.; Elliott T.B.; Pellmar T.C.; Ledney G.D.; Wound trauma increases radiation-induced mortality by activation of iNOS pathway and elevation of cytokine concentrations and bacterial infection. Radiat Res 2010,173(3),319-332","journal-title":"Radiat Res"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.lfs.2008.03.016","volume":"82","author":"Wu W.","year":"2008","unstructured":"Wu W.; Abraham L.; Ogony J.; Matthews R.; Goldstein G.; Ercal N.; Effects of N-acetylcysteine amide (NACA), a thiol antioxidant on radiation-induced cytotoxicity in Chinese hamster ovary cells. Life Sci 2008,82(21-22),1122-1130","journal-title":"Life Sci"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/(SICI)1520-636X(1996)8:1<24:AID-CHIR6>3.0.CO;2-G","volume":"8","author":"Ercal N.","year":"1996","unstructured":"Ercal N.; Luo X.; Matthews R.H.; Armstrong D.W.; In vitro study of the metabolic effects of D-amino acids. Chirality 1996,8(1),24-29","journal-title":"Chirality"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0891-5849(02)01372-2","volume":"34","author":"Neal R.","year":"2003","unstructured":"Neal R.; Matthews R.H.; Lutz P.; Ercal N.; Antioxidant role of N-acetyl cysteine isomers following high dose irradiation. Free Radic Biol Med 2003,34(6),689-695","journal-title":"Free Radic Biol Med"},{"key":"ref=144","first-page":"54","volume":"238","author":"Corcoran G.B.","year":"1986","unstructured":"Corcoran G.B.; Wong B.K.; Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D-cysteine in mice. J Pharmacol Exp Ther 1986,238(1),54-61","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/mnfr.201500031","volume":"60","author":"Yin J.","year":"2016","unstructured":"Yin J.; Ren W.; Yang G.; Duan J.; Huang X.; Fang R.; Li C.; Li T.; Yin Y.; Hou Y.; Kim S.W.; Wu G.; L-Cysteine metabolism and its nutritional implications. Mol Nutr Food Res 2016,60(1),134-146","journal-title":"Mol Nutr Food Res"},{"key":"ref=146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127142","volume":"10","author":"Brand M.","year":"2015","unstructured":"Brand M.; Sommer M.; Ellmann S.; Wuest W.; May M.S.; Eller A.; Vogt S.; Lell M.M.; Kuefner M.A.; Uder M.; Influence of different antioxidants on X-Ray induced DNA double-strand breaks (DSBs) Using \u03b3-H2AX Immunofluorescence microscopy in a preliminary study. PLoS One 2015,10(5)","journal-title":"PLoS One"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jvir.2016.10.022","volume":"28","author":"Velauthapillai N.","year":"2017","unstructured":"Velauthapillai N.; Barfett J.; Jaffer H.; Mikulis D.; Murphy K.; Antioxidants taken orally prior to diagnostic radiation exposure can prevent DNA injury. J Vasc Interv Radiol 2017,28(3),406-411","journal-title":"J Vasc Interv Radiol"},{"key":"ref=148","first-page":"516","author":"Council N.R.","year":"1999","unstructured":"Council N.R.; Health Effects of Exposure to Radon: BEIR VI 1999,516","journal-title":"Health Effects of Exposure to Radon: BEIR VI"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.mrfmmm.2017.02.004","volume":"806","author":"Wu J.","year":"2017","unstructured":"Wu J.; Zhang B.; Wuu Y.R.; Davidson M.M.; Hei T.K.; Targeted cytoplasmic irradiation and autophagy. Mutat Res 2017,806,88-97","journal-title":"Mutat Res"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10787-017-0320-9","volume":"25","author":"Buer J.K.","year":"2017","unstructured":"Buer J.K.; To stop the erosion of hope: the DMARD category and the place of semantics in modern rheumatology. Inflammopharmacology 2017,25(2),185-190","journal-title":"Inflammopharmacology"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/03007995.2016.1239191","volume":"33","author":"Mahlich J.","year":"2017","unstructured":"Mahlich J.; Sruamsiri R.; Treatment patterns of rheumatoid arthritis in Japanese hospitals and predictors of the initiation of biologic agents. Curr Med Res Opin 2017,33(1),101-107","journal-title":"Curr Med Res Opin"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/ijcp.12809","volume":"70","author":"Machado-Alba J.E.","year":"2016","unstructured":"Machado-Alba J.E.; Ruiz A.F.; Machado-Duque M.E.; Effectiveness of treatment with biologic- and disease-modifying antirheumatic drugs in rheumatoid arthritis patients in Colombia. Int J Clin Pract 2016,70(6),506-511","journal-title":"Int J Clin Pract"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/1319-2442.198118","volume":"28","author":"Muthukumar P.","year":"2017","unstructured":"Muthukumar P.; Dhanapriya J.; Gopalakrishnan N.; Dineshkumar T.; Sakthirajan R.; Balasubramaniyan T.; Evaluation of renal lesions and clinicopathologic correlation in rheumatoid arthritis. Saudi J Kidney Dis Transpl 2017,28(1),44-50","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1093\/rheumatology\/kew214","volume":"55","author":"Lange E.","year":"2016","unstructured":"Lange E.; Blizzard L.; Venn A.; Francis H.; Jones G.; Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study. Rheumatology (Oxford) 2016,55(9),1594-1600","journal-title":"Rheumatology (Oxford)"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/bph.13459","volume":"173","author":"Brancaleone V.","year":"2016","unstructured":"Brancaleone V.; Esposito I.; Gargiulo A.; Vellecco V.; Asimakopoulou A.; Citi V.; Calderone V.; Gobbetti T.; Perretti M.; Papapetropoulos A.; Bucci M.; Cirino G.; D-Penicillamine modulates hydrogen sulfide (HS) pathway through selective inhibition of cystathionine-\u03b3-lyase. Br J Pharmacol 2016,173(9),1556-1565","journal-title":"Br J Pharmacol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1756-185X.12472","volume":"20","author":"Muniraj N.","year":"2017","unstructured":"Muniraj N.; Stamp L.K.; Badiei A.; Hegde A.; Cameron V.; Bhatia M.; Hydrogen sulfide acts as a pro-inflammatory mediator in rheumatic disease. Int J Rheum Dis 2017,20(2),182-189","journal-title":"Int J Rheum Dis"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2215\/CJN.10981114","volume":"10","author":"Rhodes H.L.","year":"2015","unstructured":"Rhodes H.L.; Yarram-Smith L.; Rice S.J.; Tabaksert A.; Edwards N.; Hartley A.; Woodward M.N.; Smithson S.L.; Tomson C.; Welsh G.I.; Williams M.; Thwaites D.T.; Sayer J.A.; Coward R.J.; Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol 2015,10(7),1235-1245","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00240-019-01128-y","volume":"47","author":"Malieckal D.A.","year":"2019","unstructured":"Malieckal D.A.; Modersitzki F.; Mara K.; Enders F.T.; Asplin J.R.; Goldfarb D.S.; Effect of increasing doses of cystine-binding thiol drugs on cystine capacity in patients with cystinuria. Urolithiasis 2019,47(6),549-555","journal-title":"Urolithiasis"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.comptc.2015.10.012","volume":"1077","author":"Casta\u00f1eda-Arriaga R.","year":"2016","unstructured":"Casta\u00f1eda-Arriaga R.; Vivier-Bunge A.; Raul Alvarez-Idaboy J.; Primary antioxidant and metal-binding effects of tiopronin: A theoretical investigation of its action mechanism. Comput Theor Chem 2016,1077,48-57","journal-title":"Comput Theor Chem"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/app.30520","volume":"114","author":"Jiang T-Y.","year":"2009","unstructured":"Jiang T-Y.; Sun C-S.; Shen X.; Wang T-Y.; Wang S-L.; Development of a poloxamer analogs\/bioadhesive polymers-based in situ gelling ophthalmic delivery system for tiopronin. J Appl Polym Sci 2009,114(2),775-783","journal-title":"J Appl Polym Sci"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1159\/000308990","volume":"180","author":"Ichikawa H.","year":"1980","unstructured":"Ichikawa H.; Imaizumi K.; Tazawa Y.; Obara Y.; Ishikawa Y.; Tobari I.; Tanabe Y.; Effect of tiopronin on senile cataracts. A double-blind clinical study. Ophthalmologica 1980,180(5),293-298","journal-title":"Ophthalmologica"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2165\/00003088-198510050-00001","volume":"10","author":"Kubo S.H.","year":"1985","unstructured":"Kubo S.H.; Cody R.J.; Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review. Clin Pharmacokinet 1985,10(5),377-391","journal-title":"Clin Pharmacokinet"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/HJH.0000000000000447","volume":"33","author":"Thomopoulos C.","year":"2015","unstructured":"Thomopoulos C.; Parati G.; Zanchetti A.; Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses. J Hypertens 2015,33(2),195-211","journal-title":"J Hypertens"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1021\/bi049480n","volume":"43","author":"Natesh R.","year":"2004","unstructured":"Natesh R.; Schwager S.L.; Evans H.R.; Sturrock E.D.; Acharya K.R.; Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme. Biochemistry 2004,43(27),8718-8724","journal-title":"Biochemistry"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/ajh\/hpu237","volume":"28","author":"Chang C.H.","year":"2015","unstructured":"Chang C.H.; Lin J.W.; Caffrey J.L.; Wu L.C.; Lai M.S.; Different Angiotensin-converting enzyme inhibitors and the associations with overall and cause-specific mortalities in patients with hypertension. Am J Hypertens 2015,28(6),823-830","journal-title":"Am J Hypertens"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/hr.2014.143","volume":"38","author":"Igreja B.","year":"2015","unstructured":"Igreja B.; Pires N.M.; Bonif\u00e1cio M.J.; Loureiro A.I.; Fernandes-Lopes C.; Wright L.C.; Soares-da-Silva P.; Blood pressure-decreasing effect of etamicastat alone and in combination with antihypertensive drugs in the spontaneously hypertensive rat. Hypertens Res 2015,38(1),30-38","journal-title":"Hypertens Res"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1021\/acsinfecdis.7b00129","volume":"4","author":"B\u00fcttner D.","year":"2018","unstructured":"B\u00fcttner D.; Kramer J.S.; Klingler F.M.; Wittmann S.K.; Hartmann M.R.; Kurz C.G.; Kohnh\u00e4user D.; Weizel L.; Br\u00fcggerhoff A.; Frank D.; Steinhilber D.; Wichelhaus T.A.; Pogoryelov D.; Proschak E.; Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-\u03b2-Lactamases. ACS Infect Dis 2018,4(3),360-372","journal-title":"ACS Infect Dis"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1128\/AAC.01335-15","volume":"60","author":"Brem J.","year":"2015","unstructured":"Brem J.; van Berkel S.S.; Zollman D.; Lee S.Y.; Gileadi O.; McHugh P.J.; Walsh T.R.; McDonough M.A.; Schofield C.J.; Structural Basis of Metallo-\u03b2-Lactamase Inhibition by Captopril Stereoisomers. Antimicrob Agents Chemother 2015,60(1),142-150","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.bmcl.2016.02.007","volume":"26","author":"Yusof Y.","year":"2016","unstructured":"Yusof Y.; Tan D.T.C.; Arjomandi O.K.; Schenk G.; McGeary R.P.; Captopril analogues as metallo-\u03b2-lactamase inhibitors. Bioorg Med Chem Lett 2016,26(6),1589-1593","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17425255.2017.1251580","volume":"13","author":"Minarini A.","year":"2017","unstructured":"Minarini A.; Ferrari S.; Galletti M.; Giambalvo N.; Perrone D.; Rioli G.; Galeazzi G.M.; N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects. Expert Opin Drug Metab Toxicol 2017,13(3),279-292","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neubiorev.2015.04.015","volume":"55","year":"2015","unstructured":"Deepmala; Slattery, J.; Kumar, N.; Delhey, L.; Berk, M.; Dean, O.; Spielholz, C.; Frye, R. Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review. Neurosci Biobehav Rev 2015,55,294-321","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.expneurol.2006.03.030","volume":"201","author":"Price T.O.","year":"2006","unstructured":"Price T.O.; Uras F.; Banks W.A.; Ercal N.; A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells. Exp Neurol 2006,201(1),193-202","journal-title":"Exp Neurol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.lfs.2016.10.026","volume":"167","author":"Abareshi A.","year":"2016","unstructured":"Abareshi A.; Hosseini M.; Beheshti F.; Norouzi F.; Khazaei M.; Sadeghnia H.R.; Boskabady M.H.; Shafei M.N.; Anaeigoudari A.; The effects of captopril on lipopolysaccharide induced learning and memory impairments and the brain cytokine levels and oxidative damage in rats. Life Sci 2016,167,46-56","journal-title":"Life Sci"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s11481-016-9703-8","volume":"11","author":"Torika N.","year":"2016","unstructured":"Torika N.; Asraf K.; Roasso E.; Danon A.; Fleisher-Berkovich S.; Angiotensin converting enzyme inhibitors ameliorate brain inflammation associated with microglial activation: Possible implications for Alzheimer\u2019s Disease. J Neuroimmune Pharmacol 2016,11(4),774-785","journal-title":"J Neuroimmune Pharmacol"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/176832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T04:25:21Z","timestamp":1612412721000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/176832\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":174,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,5,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557519666191119144100","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}